BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26171429)

  • 1. Long-term results of the mucosal ablation of Barrett's esophagus: efficacy and recurrence.
    Saligram S; Tofteland N; Wani S; Gupta N; Mathur S; Vennalaganti P; Kanakadandi V; Giacchino M; Higbee A; Lim D; Rastogi A; Bansal A; Sharma P
    Endosc Int Open; 2015 Jun; 3(3):E189-94. PubMed ID: 26171429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
    Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
    Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review.
    Luigiano C; Iabichino G; Eusebi LH; Arena M; Consolo P; Morace C; Opocher E; Mangiavillano B
    Gastroenterol Res Pract; 2016; 2016():4249510. PubMed ID: 28070182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
    Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
    Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Sharma P; Overholt BF; Wolfsen HC; Sampliner RE; Wang KK; Galanko JA; Bronner MP; Goldblum JR; Bennett AE; Jobe BA; Eisen GM; Fennerty MB; Hunter JG; Fleischer DE; Sharma VK; Hawes RH; Hoffman BJ; Rothstein RI; Gordon SR; Mashimo H; Chang KJ; Muthusamy VR; Edmundowicz SA; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Falk GW; Kimmey MB; Madanick RD; Chak A; Lightdale CJ
    N Engl J Med; 2009 May; 360(22):2277-88. PubMed ID: 19474425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?
    Singh T; Sanaka MR; Thota PN
    World J Gastrointest Endosc; 2018 Sep; 10(9):165-174. PubMed ID: 30283599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of Barrett's segment predicts failure of eradication in radiofrequency ablation for Barrett's esophagus: a retrospective cohort study.
    Luckett T; Allamneni C; Cowley K; Eick J; Gullick A; Peter S
    BMC Gastroenterol; 2018 May; 18(1):67. PubMed ID: 29783927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-art management of dysplastic Barrett's esophagus.
    Vantanasiri K; Iyer PG
    Gastroenterol Rep (Oxf); 2022; 10():goac068. PubMed ID: 36381221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
    Dunbar KB
    Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia.
    Hernandez JC; Reicher S; Chung D; Pham BV; Tsai F; Disibio G; French S; Eysselein VE
    Endoscopy; 2008 May; 40(5):388-92. PubMed ID: 18459075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.
    Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Krishnadath KK; Ten Kate F; Fockens P; Bergman JJ
    Endoscopy; 2008 May; 40(5):359-69. PubMed ID: 18494131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized Surveillance Intervals Following Endoscopic Eradication of Dysplastic Barrett's Esophagus: An International Cohort Study.
    Kahn A; Crook J; Heckman MG; Wieczorek MA; Sami S; Snyder D; Agarwal S; Santiago J; Fernandez-Sordo JO; Tan WK; Lansing R; Wang KK; Ragunath K; DiPietro M; Wolfsen H; Ramirez F; Fleischer D; Leggett CL; Iyer PG
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2763-2771.e3. PubMed ID: 35245702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
    Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
    Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsquamous intestinal metaplasia after ablation of Barrett's esophagus: frequency and importance.
    Mashimo H
    Curr Opin Gastroenterol; 2013 Jul; 29(4):454-9. PubMed ID: 23674187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.